NCT04301583

Procyanidin B2 Enriched Cocoa Effects on Mitochondrial Biogenesis

Universidad Europea de Madrid·ClinicalTrials.gov·dietary supplementCompleted
View on ClinicalTrials.gov
Study focus
Disease/Condition
Athletes
Drug/Device/Intervention
procyanidin B2 enriched cocoa
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Universidad Europea de Madrid
Location
Villaviciosa de Odón, Spain
Timeline & enrollment
Phase
N/A
Start date
Jun 01, 2020
End date
Sep 01, 2020
Enrollment
38 participants
Primary outcome

Difference in mitochondrial number,Difference in exercise performance

Summary

The purpose of this study is to test how cocoa-rich procyanidin B2 affect the mitochondrial
 exercise adaptations.

ICD-10 classifications
Examination for participation in sportStriking against or struck by sports equipmentRoutine general health check-up of sports teams
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04301583
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04301583 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidad Europea de Madrid and is currently Completed. The study focuses on Athletes. Target enrollment is 38 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.